IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v34y2016i4d10.1007_s40273-015-0327-2.html
   My bibliography  Save this article

AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users

Author

Listed:
  • P. Vemer

    (University of Groningen
    University of Groningen, Pharmacoepidemiology and Pharmacoeconomics (PE2))

  • I. Corro Ramos

    (Erasmus University)

  • G. A. K. Voorn

    (Biometris, Wageningen University and Research)

  • M. J. Al

    (Erasmus University)

  • T. L. Feenstra

    (University of Groningen
    National Institute for Public Health and the Environment (RIVM))

Abstract

Background A trade-off exists between building confidence in health-economic (HE) decision models and the use of scarce resources. We aimed to create a practical tool providing model users with a structured view into the validation status of HE decision models, to address this trade-off. Methods A Delphi panel was organized, and was completed by a workshop during an international conference. The proposed tool was constructed iteratively based on comments from, and the discussion amongst, panellists. During the Delphi process, comments were solicited on the importance and feasibility of possible validation techniques for modellers, their relevance for decision makers, and the overall structure and formulation in the tool. Results The panel consisted of 47 experts in HE modelling and HE decision making from various professional and international backgrounds. In addition, 50 discussants actively engaged in the discussion at the conference workshop and returned 19 questionnaires with additional comments. The final version consists of 13 items covering all relevant aspects of HE decision models: the conceptual model, the input data, the implemented software program, and the model outcomes. Conclusions Assessment of the Validation Status of Health-Economic decision models (AdViSHE) is a validation-assessment tool in which model developers report in a systematic way both on validation efforts performed and on their outcomes. Subsequently, model users can establish whether confidence in the model is justified or whether additional validation efforts should be undertaken. In this way, AdViSHE enhances transparency of the validation status of HE models and supports efficient model validation.

Suggested Citation

  • P. Vemer & I. Corro Ramos & G. A. K. Voorn & M. J. Al & T. L. Feenstra, 2016. "AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users," PharmacoEconomics, Springer, vol. 34(4), pages 349-361, April.
  • Handle: RePEc:spr:pharme:v:34:y:2016:i:4:d:10.1007_s40273-015-0327-2
    DOI: 10.1007/s40273-015-0327-2
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40273-015-0327-2
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40273-015-0327-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Kleijnen, Jack P.C., 2011. "Ethical issues in engineering models : An operations researcher's reflections," Other publications TiSEM 88caba9e-1d78-47d7-9a0b-b, Tilburg University, School of Economics and Management.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Prajakta P. Masurkar & Haluk Damgacioglu & Ashish A. Deshmukh & Meghana V. Trivedi, 2023. "Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2− Metastatic Breast Cancer in Postmenopausal Women in the USA," PharmacoEconomics, Springer, vol. 41(6), pages 709-718, June.
    2. T I Armina Padmasawitri & Gerardus W Frederix & Bachti Alisjahbana & Olaf Klungel & Anke M Hövels, 2018. "Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review," PLOS ONE, Public Library of Science, vol. 13(5), pages 1-20, May.
    3. Penny R. Breeze & Hazel Squires & Kate Ennis & Petra Meier & Kate Hayes & Nik Lomax & Alan Shiell & Frank Kee & Frank de Vocht & Martin O’Flaherty & Nigel Gilbert & Robin Purshouse & Stewart Robinson , 2023. "Guidance on the use of complex systems models for economic evaluations of public health interventions," Health Economics, John Wiley & Sons, Ltd., vol. 32(7), pages 1603-1625, July.
    4. Bent Estler & Volker Rudolph & Yana Seleznova & Arim Shukri & Stephanie Stock & Dirk Müller, 2023. "Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(3), pages 349-358, April.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      More about this item

      Statistics

      Access and download statistics

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:34:y:2016:i:4:d:10.1007_s40273-015-0327-2. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.